Authors
Latest:
Effectiveness of Minimally Invasive Parafascicular Surgery in Intracerebral Hemorrhage: Andrew Russman, DOThe head of the Stroke Program and Medical Director of the Comprehensive Stroke Center at Cleveland Clinic provided perspective on the ENRICH trial, the first positive surgical trial for intracerebral hemorrhage. [WATCH TIME: 5 minutes]
Latest:
Peter Nakaji, MD: The State of Science for Epilepsy SurgeryThe chair of the Department of Neurosurgery at Banner-University Medical Center discusses the current state of the science being done in the realm of epilepsy surgery.
Latest:
Katrina Celis, MD: Genetics and Their Role in Alzheimer Research, Clinical CareThe postdoctoral fellow at the University of Miami Miller School of Medicine detailed the role that increased APOE ε4 expression can have on future research and clinical care.
Latest:
Naeem Khan, MD: Ticagrelor Shines in Phase 3 THALES TrialThe vice president of AstraZeneca’s Cardiovascular and Metabolic Diseases Portfolio detailed the results from the phase 3 THALES trial, and where ticagrelor stands among other FDA approved stroke treatments.
Latest:
The Future Outlook for Alzheimer’s DiseaseSharon Cohen, MD, and Marwan Sabbagh, MD, share their final thoughts on Alzheimer's disease and offer advice on strategies to reduce the risk of developing AD and slow the progression of the disease for those already affected.
Latest:
Kathleen Hawker, MD: Clinical Findings for Satralizumab in Treating NMOSDThe group medical director of neuroscience at Genentech spoke to the findings recently presented at the 6th Annual Meeting of the European Academy of Neurology.
Latest:
Dawn Buse, PhD: Inappropriate Prescriptions in Acute, Preventive Migraine TreatmentThe clinical professor of neurology at Albert Einstein College of Medicine spoke to the findings of the OVERCOME study, and how recent literature has suggested that improper prescriptions and medication use in migraine have been ongoing in spite of the current recommendations.
Latest:
Amy Sullivan, PsyD: Personalized Approach to Fatigue in Multiple SclerosisThe Director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about how she approaches fatigue in MS from a behavioral standpoint.
Latest:
Jeff Waugh, MD, PhD: Viewing Striatal Injury More GranularlyDespite some mistrusting the abilities of imaging to aid in therapeutic development, a new MRI method could better inform the anatomical understanding of the striatum.
Latest:
Future Directions and Unanswered Questions Regarding S1P Modulator ReceptorsIn this episode, Patricia Coyle, MD, FAAN, gave clinical insight on some of the next steps regarding S1P-modulating therapies, including some of the advantages of newer generation agents and the need for future studies to investigate benefits and limitations to each.
Latest:
Dominic Pelle, MD: Improving Patient-Reported Outcomes in Spine SurgeryThe spine surgeon in the Center for Spine Health at Cleveland Clinic spoke to the importance of improving patient-reported outcomes and ensuring consistent communication with patients undergoing spine surgery.
Latest:
Promising Diagnostic Approaches Emerging for Brain Pathologies: James Leverenz, MDThe director of the Cleveland Lou Ruvo Center for Brain Health at Cleveland Clinic discussed new diagnostic techniques that show promise for advancing the understanding of brain pathologies like Alzheimer and Lewy Body diseases. [WATCH TIME: 3 minutes]
Latest:
Jerrold L. Vitek, MD, PhD: Multiple Independent Contact Current-Controlled DBS TechnologyThe professor and head of the department of neurology at the University of Minnesota discussed what multiple independent contact current-controlled devices offer physicians conducting deep brain stimulation.
Latest:
Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic HeadacheMia Minen, MD, MPH, sat down for an interview to discuss why behavioral therapies could be an effective and easily accessible treatment for posttraumatic headaches following events like concussions.
Latest:
Eugenia Trushina, PhD: Communication and Learning Through CollaborationFor the associate professor of neurology, learning, listening, and collaborating are the keys to improving the field of care.
Latest:
Narrowing Down Effective Medications, Classes of Treatments for Migraine: Chia-Chun Chiang, MDThe associate professor of neurology at Mayo Clinic Rochester discussed specific findings from a simultaneous comparison of migraine medications in which certain treatments and classes were more effective. [WATCH TIME: 3 minutes]
Latest:
The Potential of Blood Tests to Improve Screening and Monitoring in Alzheimer Disease Clinical Trials: Ronald C. Petersen, MD, PhDThe director of the Alzheimer’s Disease Research Center at Mayo Clinic detailed the current issues with access and affordability to critical biomarkers in the screening and monitoring of patients in Alzheimer disease trials. [WATCH TIME: 3 minutes]
Latest:
The Importance of a Globally Aligned, Standardized MRI Protocol for MSLeaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.
Latest:
Pimavanserin Safety Data and Future Research: Clive Ballard, MDClive Ballard, MD, spoke on the safety data of pimavanserin, which was presented at the 2021 AAIC meeting, held from July 26-30.
Latest:
Ari Green, MD, MCR: Remyelination in Multiple SclerosisThe medical director of the UCSF Multiple Sclerosis Center discussed the idea behind remyelination and shared his thoughts on what the best shot at developing a therapy might be.
Latest:
Navigating the Shift from Pediatric to Adult Care Systems in Epilepsy: Danielle Andrade, MD, MSc, FRCPCThe director of the Adult Genetic Epilepsy Program at the University of Toronto talked about the critical issues experienced by patients who transition from pediatric to adult care in epilepsy. [WATCH TIME: 9 minutes]
Latest:
Advancing Multiple Sclerosis Diagnosis With the 2024 Criteria Revision: Xavier Montalban, MD, PhDThe chair of neurology at Hospital Universitari Vall d’Hebron talked about the revision of the MS diagnostic criteria that will integrate new evidence, biological markers, and advanced MRI findings to enable earlier and more precise diagnoses. [WATCH TIME: 4 minutes]
